Back
Adverum Biotechnologies Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
ADVM
Adverum Biotechnologies
Last Price:
6.05
Seasonality Move:
22.26%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Adverum Biotechnologies Price Quote
$6.05
+0.30 (+5.22%)
(Updated: November 22, 2024 at 5:55 PM ET)
Adverum Biotechnologies Key Stats
Sell
29
Adverum Biotechnologies (ADVM)
is a Sell
Day range:
$5.70 - $6.16
52-week range:
$5.70 - $29.70
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.83%
Volume:
873.6K
Avg. volume:
212.9K
1-year change:
-33.14%
Market cap:
$119.6M
Revenue:
$3.6M
EPS:
$-6.01
How Much Does Adverum Biotechnologies Make?
Data Unavailable
Is Adverum Biotechnologies Growing As A Company?
Data Unavailable
Adverum Biotechnologies Stock Price Performance
-
Did Adverum Biotechnologies Stock Go Up Last Month?
Adverum Biotechnologies share price went down by -30.39% last month -
Did ADVM's Share Price Rise Over The Last Year?
ADVM share price fell by -33.14% over the past 1 year
What Is Adverum Biotechnologies 52-Week High & Low?
-
What Is Adverum Biotechnologies’s 52-Week High Share Price?
Adverum Biotechnologies has traded as high as $29.70 over the past 52 weeks -
What Is Adverum Biotechnologies’s 52-Week Low Share Price?
Adverum Biotechnologies has traded as low as $5.70 over the past 52 weeks
Adverum Biotechnologies Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Adverum Biotechnologies?
-
How Much Debt Does Adverum Biotechnologies Have?
Total long term debt quarterly is $0 -
How Much Cash Does Adverum Biotechnologies Have?
Cash and short term investments quarterly total is $153.2M -
What Is Adverum Biotechnologies’s Book Value Per Share?
Book value per share is 6.93
Is Adverum Biotechnologies Cash Flow Positive?
-
What Is ADVM Cash Flow From Operations?
Cash flow from operations (TTM) is -$85.5M -
What Is Adverum Biotechnologies’s Cash Flow From Financing?
Cash flow from financing (TTM) is $119.9M -
What Is Adverum Biotechnologies’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$47.6M
Adverum Biotechnologies Return On Invested Capital
-
Is Management Doing A Good Job?
ADVM return on invested capital is -69.14% -
What Is Adverum Biotechnologies Return On Assets?
ROA measures how assets are converting to revenues and is -41.8% -
What Is ADVM Return On Equity?
ROE is a measure of profitability and is -69.14%
Adverum Biotechnologies Earnings Date & Stock Price
-
What Is Adverum Biotechnologies's Stock Price Today?
A single share of ADVM can be purchased today for 5.75 -
What Is Adverum Biotechnologies’s Stock Symbol?
Adverum Biotechnologies trades on the nasdaq under the ticker symbol: ADVM -
When Is Adverum Biotechnologies’s Next Earnings Date?
The next quarterly earnings date for Adverum Biotechnologies is scheduled on March 18, 2025 -
When Is ADVM's next ex-dividend date?
Adverum Biotechnologies's next ex-dividend date is November 23, 2024 -
How To Buy Adverum Biotechnologies Stock?
You can buy Adverum Biotechnologies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Adverum Biotechnologies Competitors
-
Who Are Adverum Biotechnologies's Competitors?
Below is a list of companies who compete with Adverum Biotechnologies or are related in some way:
Adverum Biotechnologies Dividend Yield
-
What Is ADVM Dividend Yield?
Adverum Biotechnologies’s dividend yield currently is 0% -
What Is Adverum Biotechnologies’s Payout Ratio?
Adverum Biotechnologies’s payout ratio is 0% -
When Did Adverum Biotechnologies Last Pay A Dividend?
The latest dividend pay date is November 23, 2024 -
What Is Adverum Biotechnologies’s Dividend Per Share?
Adverum Biotechnologies pays a dividend of $0.00 per share
Adverum Biotechnologies Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0.13% |
| Revenue: | 0% | 1500% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 30.29 |
| Upside from Last Price: | 426.71% |